Check the

INSTRATA LTD.

Company
INSTRATA LTD. (04229163)

INSTRATA

Phone: +44 (0)1223 301 101
C⁺ rating

ABOUT INSTRATA LTD.

Whether the brief is highly specific or wildly ambiguous, Rachel�s expertise bridges the gap between the technology and the end-user to deliver successful people-centred products, services and systems.

Commercial Business

Rachel works with large corporations to create business propositions that tap into new and innovative technology. This includes both identifying uses for new technology and scoping areas where opportunities for new technologies exist.

Where a new technology is being developed, Rachel will work with the team to research its potential end-users and identify their specific product needs. This vital understanding helps to define the technology, ensuring it reaches its full market potential. Rachel�s skill is bringing together product and market potential to create a holistic solution that manifests in a tangible and designed product or service.

Similarly, when companies look to expand their technology into new sectors, Rachel conducts the vital background research to identify possible technology partnerships and establishes the beneficial relationships. Rachel works together with partners to outline mutually valuable projects. Rachel puts together the business propositions and manages the projects through to completion.

Working with Research & Development teams, both corporate and academic, Rachel helps to explore new technology ideas and then create working demonstrators that bring those ideas to life and show their potential.

Most importantly it involves managing the transfer of the idea into a business itself, ensuring its use by existing teams or helping to establish new units that will exploit it for the company�s benefit.

To revitalize Nokia�s market share in the face of tough competition from the iPhone. Nokia wanted to improve their development process so that more �emotionally appealing� products passed their development criteria and reached market.

Rachel and her team worked closely with end-users in five carefully selected countries. This provided a real understanding of the role Nokia�s handsets played in people�s lives, both from a user and a cultural perspective. Rachel used this unique insight to develop a framework that mapped the handset�s emotional qualities and the role they play in different areas of people�s lives. Rachel was then able to use this framework to develop value statements that could accurately deliver metrics.

Rachel�s work contributed to a major cultural and technological shift within Nokia. Emotional appeal is now a valued and integral aspect of Nokia�s handset development process, helping Nokia to produce the handsets that customers really want.

Helping to shape Microsoft�s platform development

To inform and support Microsoft�s development of innovative community technologies based on the needs and activities of an exemplar community, amateur musicians. We were expected to develop novel concepts for the product groups, usable patents and academic papers in world class publications.

Rachel led an extensive research study of the amateur musician community. This showed how amateur musicians employ a plethora of online services to sustain local fan bases, reach out to new fans, collaborate internationally, and actively promote both digital and material products. Rachel helped to create extremely novel concepts in this space and to translate these into interesting extensions for Microsoft products that help to differentiate them in the global marketplace.

Rachel helped to create many concepts that are successfully being rolled out into Microsoft products. The concepts included event-oriented promotion tools, community-oriented analytics, tangible and embedded products, and limited-edition digital experiences. These have also had great feedback from the community itself.

To develop a health data platform that provides digital health companies with a data service that allows them to gather the evidence they need to support a business case. The lack of such a service blocks the deployment of innovative products and services that could both improve patient care and provide significant efficiencies.

Gathering personal health data has become highly controversial. We needed to find a new way of understanding the evidence for digital health products.

Rachel�s work provided the Digital Catapult with a number of options for projects designed to break down the barriers. The white paper Rachel produced has provided Digital Catapult with all the intelligence they need to make informed decisions on the right projects to initiate. When these projects go ahead, companies will be able to gather the crucial evidence they need to validate their products and deploy them effectively. This will lead to improvements in patients� health and greater efficiencies in the system.

Helping healthcare funding to maximise its impact

Rachel brought together discussion groups made up of representatives from multi-disciplinary clinical teams. These met in the health clinics themselves, where the setting helped to stimulate and ground ideas. Rachel based the discussions around a process familiar to all stakeholders - care pathways. These were presented with highly engaging visuals that guided and structured the conversations by providing a tangible entity around which people could talk. Rather than searching for solutions, participants were asked to identify challenges and opportunities. This allowed a much broader range of solutions to be considered, including ideas from industries outside of the clinical sphere. This all ensured the discussion groups were positively focused and highly generative.

From the findings Rachel was able to scope a tender briefing document that focused on specific, high priority challenges that can realistically be solved. She threw open these challenges to an exceptionally diverse set of suppliers who were able to offer practical solutions based on innovative new technologies. Rachel�s work has also provided business with a real understanding of the challenges faced by clinicians and is enabling more effective procurement for the NHS.

KEY FINANCES

Year
2017
Assets
£0k ▼ £-8.91k (-100.00 %)
Cash
£0k ▼ £-8.88k (-100.00 %)
Liabilities
£0.09k ▼ £-3.85k (-97.72 %)
Net Worth
£-0.09k ▼ £-5.06k (-101.81 %)

REGISTRATION INFO

Company name
INSTRATA LTD.
Company number
04229163
Status
Active
Categroy
Private Limited Company
Date of Incorporation
05 Jun 2001
Age - 23 years
Home Country
United Kingdom

CONTACTS

Website
instrata.co.uk
Phones
+44 (0)1223 301 101
01223 301 101
Registered Address
12 WARKWORTH STREET,
CAMBRIDGE,
CAMBRIDGESHIRE,
CB1 1EG

ECONOMIC ACTIVITIES

74990
Non-trading company

LAST EVENTS

18 Aug 2016
Total exemption full accounts made up to 30 June 2016
21 Jun 2016
Annual return made up to 5 June 2016 with full list of shareholders Statement of capital on 2016-06-21 GBP 2
17 Nov 2015
Total exemption small company accounts made up to 30 June 2015

See Also


Last update 2018

INSTRATA LTD. DIRECTORS

Christine King

  Acting
Appointed
05 June 2001
Role
Secretary
Address
Tudor Cottages, Common Road, Weston Colville, Cambridge, CB1 5NS
Name
KING, Christine

Jones Rachel Dr

  Acting
Appointed
05 June 2001
Occupation
It Consultant
Role
Director
Age
63
Nationality
British
Address
12 Warkworth Street, Cambridge, Cambridgeshire, CB1 1EG
Name
JONES, Rachel, Dr

Stephen John Mead

  Acting
Appointed
18 July 2008
Occupation
Project Manager
Role
Director
Age
76
Nationality
British
Address
12 Warkworth Street, Cambridge, CB1 1EG
Name
MEAD, Stephen John

CHETTLEBURGHS SECRETARIAL LTD

  Resigned
Appointed
05 June 2001
Resigned
05 June 2001
Role
Nominee Secretary
Address
Temple House, 20 Holywell Row, London, EC2A 4XH
Name
CHETTLEBURGHS SECRETARIAL LTD

REVIEWS


Check The Company
Normal according to the company’s financial health.